HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Ingerslev Selected Research

recombinant FVIIa (rFVIIa)

9/2016Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
3/2011Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A.
3/2009Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
1/2009Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
6/2008Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
1/2007Use of recombinant factor VIIa for emergency reversal of anticoagulation.
1/2006Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
11/2005Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
1/2004Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
1/2004Thromboelastography and recombinant factor VIIa-hemophilia and beyond.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Ingerslev Research Topics

Disease

29Hemorrhage
09/2016 - 01/2000
23Hemophilia A (Haemophilia)
05/2014 - 01/2000
12Thrombosis (Thrombus)
07/2009 - 04/2000
9von Willebrand Diseases (von Willebrand's Disease)
09/2010 - 03/2000
5Factor VII Deficiency (Hypoproconvertinemia)
11/2015 - 04/2005
5Type 1 von Willebrand Disease
09/2010 - 04/2006
3Hemophilia B (Haemophilia B)
05/2009 - 03/2000
3Hyperhomocysteinemia
10/2000 - 04/2000
2Thrombophilia
03/2001 - 05/2000
1Menorrhagia
09/2016
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
09/2012
1Hepatocellular Carcinoma (Hepatoma)
09/2012
1Neoplasms (Cancer)
09/2012
1Prostatic Neoplasms (Prostate Cancer)
09/2012
1Pain (Aches)
11/2010
1Afibrinogenemia (Fibrinogen Deficiency)
07/2009
1Bernard-Soulier Syndrome (Giant Platelet Syndrome)
01/2009
1Thrombocytopenia (Thrombopenia)
01/2009
1Heart Arrest (Cardiac Arrest)
01/2009
1Hypothermia
01/2009
1Hypertension (High Blood Pressure)
01/2009
1Atrial Fibrillation
01/2009
1Infertility (Sterility)
03/2006
1Vascular System Injuries
01/2006
1Type 2 Diabetes Mellitus (MODY)
08/2002
1Insulin Resistance
08/2002
1Heart Diseases (Heart Disease)
08/2002
1Stable Angina
10/2001
1Fibrosis (Cirrhosis)
10/2001
1Thrombasthenia (Glanzmann Thrombasthenia)
10/2001
1Varicose Veins (Varicose Vein)
10/2001
1Disseminated Intravascular Coagulation
09/2001
1Wounds and Injuries (Trauma)
09/2001
1Vascular Diseases (Vascular Disease)
07/2001
1Hepatitis
11/2000

Drug/Important Bio-Agent (IBA)

15recombinant FVIIa (rFVIIa)FDA Link
09/2016 - 01/2000
13Factor VIII (Coagulation Factor VIII)IBA
05/2014 - 01/2000
12von Willebrand FactorIBA
09/2010 - 03/2000
7Hemostatics (Antihemorrhagics)IBA
07/2009 - 01/2000
6Fibrinogen (Factor I)FDA Link
04/2012 - 08/2002
6Thromboplastin (Tissue Factor)IBA
03/2006 - 07/2003
5Factor VII (Proconvertin)IBA
09/2016 - 04/2005
5ThrombinFDA Link
05/2013 - 03/2003
5Biomarkers (Surrogate Marker)IBA
11/2010 - 04/2006
4Factor IX (Coagulation Factor IX)FDA LinkGeneric
03/2006 - 01/2000
4Factor VIIa (Activated Factor VII)IBA
01/2006 - 09/2001
3Blood Coagulation Factors (Coagulation Factor)IBA
04/2012 - 10/2001
3Heparin (Liquaemin)FDA LinkGeneric
01/2009 - 03/2001
3Pharmaceutical PreparationsIBA
02/2004 - 09/2001
2Prothrombin (Factor II)IBA
07/2009 - 11/2005
2Starch (Cornstarch)IBA
05/2009 - 03/2005
2AnticoagulantsIBA
01/2007 - 11/2005
2AntibodiesIBA
03/2006 - 01/2006
2HomocysteineIBA
10/2000 - 04/2000
2DNA (Deoxyribonucleic Acid)IBA
03/2000 - 03/2000
1IronIBA
09/2016
1sugar formulated recombinant FVIIIIBA
05/2014
1Sucrose (Saccharose)IBA
05/2014
1FibrinIBA
05/2013
1Factor XIII (Coagulation Factor XIII)IBA
03/2011
1Pain-FreeIBA
11/2010
1LatexIBA
09/2010
1AntigensIBA
09/2010
1HES 130-0.4IBA
05/2009
1Crystalloid SolutionsIBA
03/2009
1RistocetinIBA
01/2009
1NN1731IBA
06/2008
1Tranexamic Acid (AMCA)FDA Link
12/2007
1ganirelixFDA Link
03/2006
1LigandsIBA
01/2006
1CoagulantsIBA
01/2006
1Dextrans (Dextran)FDA Link
03/2005
1Plasma SubstitutesIBA
03/2005
1Vitamin KFDA Link
01/2004
1LipidsIBA
08/2002
1Fibronectins (Fibronectin)IBA
08/2002
1Indicators and Reagents (Reagents)IBA
08/2002
1AlbuminsIBA
08/2002
1factor VII clotting antigenIBA
10/2001
1Warfarin (Coumadin)FDA LinkGeneric
11/2000
1Illicit Drugs (Recreational Drugs)IBA
11/2000
1Heme (Haem)IBA
11/2000

Therapy/Procedure

12Therapeutics
09/2016 - 03/2001
2Operative Surgical Procedures
09/2016 - 01/2000
2Platelet Transfusion (Blood Platelet Transfusions)
01/2009 - 10/2001
1Hysterectomy
09/2016
1Drug Therapy (Chemotherapy)
09/2012
1Radiotherapy
09/2012
1Minor Surgical Procedures (Minor Surgery)
05/2012
1Resuscitation
05/2009
1Cystectomy
05/2009
1Arthroplasty
03/2009
1Extracorporeal Circulation
01/2009
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2009
1Sternotomy
01/2009
1Tooth Extraction (Tooth Extractions)
04/2006
1Contraindications
09/2001
1Hemostatic Techniques
09/2001
1Ligation
07/2001